Not much happening with Clinuvel: share price drifting lower on very low volume, lack of substantive news, Chairman selling, Germany treating 20 patients per year only, no NDA submission reported, no news on FDA vitiligo progress, NICE stonewalling- decision deferred for 12 months, no news regarding further EU countries, net profit for 6 months of 2 million.
Reading Wolgen’s CEO outlook Feb 17 he still sounds confident that things are on track. Clinuvel shareholders are used to being patient and I think I will look for excitement elsewhere and put this in the bottom drawer for 12 more months.
Not much happening with Clinuvel: share price drifting lower on...
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.28 |
Change
-0.250(1.85%) |
Mkt cap ! $741.1M | |||
| Open | High | Low | Value | Volume |
| $13.55 | $13.62 | $13.25 | $1.157M | 86.45K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 227 | $13.28 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.42 | 228 | 1 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| CUV (ASX) Chart |
